Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ANCOBON | Bausch Health Companies | N-017001 RX | 1982-01-01 | 2 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
ancobon | New Drug Application | 2022-02-02 |
flucytosine | ANDA | 2024-12-02 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Infections | D007239 | EFO_0000544 | — | — | 1 | — | — | — | 1 |
Drug common name | Flucytosine |
INN | flucytosine |
Description | Flucytosine is an organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections. It has a role as a prodrug. It is an organofluorine compound, a pyrimidone, an aminopyrimidine, a nucleoside analogue and a pyrimidine antifungal drug. It is functionally related to a cytosine. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Nc1nc(=O)[nH]cc1F |
PDB | — |
CAS-ID | 2022-85-7 |
RxCUI | — |
ChEMBL ID | CHEMBL1463 |
ChEBI ID | 5100 |
PubChem CID | 3366 |
DrugBank | DB01099 |
UNII ID | D83282DT06 (ChemIDplus, GSRS) |